Your browser doesn't support javascript.
loading
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert, Nathalie L; Galldiks, Norbert; Ellingson, Benjamin M; van den Bent, Martin J; Chang, Susan M; Cicone, Francesco; de Groot, John; Koh, Eng-Siew; Law, Ian; Le Rhun, Emilie; Mair, Maximilian J; Minniti, Giuseppe; Rudà, Roberta; Scott, Andrew M; Short, Susan C; Smits, Marion; Suchorska, Bogdana; Tolboom, Nelleke; Traub-Weidinger, Tatjana; Tonn, Joerg-Christian; Verger, Antoine; Weller, Michael; Wen, Patrick Y; Preusser, Matthias.
Afiliação
  • Albert NL; Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany.
  • Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Institute of Neuroscience and Medicine (INM-3), Research Center Juelich, Juelich, Germany; Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldo
  • Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • van den Bent MJ; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Chang SM; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Cicone F; Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • de Groot J; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Koh ES; Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centre, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • Law I; Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen, Denmark.
  • Le Rhun E; Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland; Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
  • Mair MJ; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy; IRCCS Neuromed, Pozzilli IS, Italy.
  • Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University of Turin and City of Health and Science of Turin, Turin, Italy.
  • Scott AM; Department of Molecular Imaging and Therapy, Austin Health and University of Melbourne, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia.
  • Short SC; Leeds Institute of Medical Research at St James's, The University of Leeds, Leeds, UK.
  • Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, Netherlands; Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, Netherlands; Medical Delta, Delft, Netherlands.
  • Suchorska B; Department of Neurosurgery, Heidelberg University Hospital, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
  • Tolboom N; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands.
  • Traub-Weidinger T; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Tonn JC; Department of Neurosurgery, LMU Hospital, LMU Munich, Munich, Germany.
  • Verger A; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy and IADI INSERM UMR 1254, Universitè de Lorraine, Nancy, France.
  • Weller M; Department of Neurology, University Hospital Zurich, Zurich, Switzerland; Department of Neurology, University of Zurich, Zurich, Switzerland.
  • Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: matthias.preusser@meduniwien.ac.at.
Lancet Oncol ; 25(1): e29-e41, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38181810
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioma / Neurologia Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioma / Neurologia Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha